MeltingPoint:>170oC(dec.) Density:1.314±0.06g/cm3(Predicted) Storage conditions:20°C Solubility:solubleinDMSO(>25mg/ml) Form:solida Aidity coefficient(pKa)10.75±0.46(Predicted) Color:light yellow low Stability:it can be storedin solution in DMSO at-20°C for up to 3 months. USE:vepatavir is an NS5A inhibitor in patients with hepatitis C (HCV) infection.It is used to treat adult patients infected with hepatitis C virus types 1 to 6. It can be used alone for patients without cirrhosis or compensated cirrhosis, or in combination with ribavirin for the treatment of patients with decompensated cirrhosis.
0.00
0.00
CAS: 1377049-84-7
MeltingPoint:>170oC(dec.) Density:1.314±0.06g/cm3(Predicted) Storage conditions:20°C Solubility:solubleinDMSO(>25mg/ml) Form:solida Aidity coefficient(pKa)10.75±0.46(Predicted) Color:light yellow low Stability:it can be storedin solution in DMSO at-20°C for up to 3 months. USE:vepatavir is an NS5A inhibitor in patients with hepatitis C (HCV) infection.It is used to treat adult patients infected with hepatitis C virus types 1 to 6. It can be used alone for patients without cirrhosis or compensated cirrhosis, or in combination with ribavirin for the treatment of patients with decompensated cirrhosis.